Fundraising Fox

Cardiac Dimensions

Kirkland, US · Founded 2001 · 77 employees on LinkedIn · 8 known investors

Cardiac Dimensions develops medical technology to treat heart failure caused by functional mitral regurgitation (FMR), aiming to address underlying causes rather than symptoms. The company serves heart failure patients and clinicians, with operations in the United States, Australia, and Germany.

Founders & leadership

FA
Frederick A. StewartExecutive
RW
Rick WypychExecutive

Board

KW
Kurt WheelerBoard director
NE
Nathan EveryBoard director
DC
Douglas C. FisherBoard director
GB
Gerry BrunkBoard director
WJ
W. James FitzsimmonsBoard director
RO
Richard O. MartinBoard director

Investors · 8

Also in the syndicate · 2

Horizon 3 HealthcareHostplus

Funding

SEC filings, press & company announcements

$54.2M disclosed across 2 of 3 rounds · 2013–2025

$1.2MraisedMar 2014 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kurt WheelerDirector
  • Frederick A. StewartExecutive Officer, Director
  • Richard O. MartinDirector
  • Nathan EveryDirector
  • Douglas C. FisherDirector
  • Gerry BrunkDirector
  • Rick WypychExecutive Officer
  • W. James FitzsimmonsDirector
Offering amount
$1.2M
Amount sold
$1.2M
First sale
Dec 2013
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Cardiac Dimensions went on to found or lead other companies.

Competitors · 5

by search overlap
Rf Surgical5 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Power5 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Oup3 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Filo3 shared keywordsFilo offers personalized, goal-based online tutoring through live 1-on-1 sessions with expert tutors, covering K-12 subjects, college courses, and competitive exams such as JEE, NEET, SSC, Banking, and Railways. Its programs include structured private courses with progress tracking, assignments, doubt-clearing, and AI-powered learning tools for students.
Topera3 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.

Companies competing with Cardiac Dimensions for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Cardiac Dimensions do?
Cardiac Dimensions develops medical technology to treat heart failure caused by functional mitral regurgitation (FMR), aiming to address underlying causes rather than symptoms. The company serves heart failure patients and clinicians, with operations in the United States, Australia, and Germany.
Who are Cardiac Dimensions's investors?
Cardiac Dimensions's investors include APERTURE Venture Partners, Lumira Ventures, Redbus Ventures, Ally Bridge Group, Claret Capital Partners, M.H. Carnegie & Co..
How much funding has Cardiac Dimensions raised?
Cardiac Dimensions has disclosed $54.2M raised across 2 of its 3 known rounds.
Where is Cardiac Dimensions headquartered?
Cardiac Dimensions is headquartered in Kirkland, US.